{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:12:15Z","timestamp":1792735935852,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1,15]]},"DOI":"10.1093\/cid\/cis886","type":"journal-article","created":{"date-parts":[[2012,10,16]],"date-time":"2012-10-16T21:48:42Z","timestamp":1350424122000},"page":"195-203","source":"Crossref","is-referenced-by-count":109,"title":["Nifurtimox-Eflornithine Combination Therapy for Second-Stage Gambiense Human African Trypanosomiasis: M\u00e9decins Sans Fronti\u00e8res Experience in the Democratic Republic of the Congo"],"prefix":"10.1093","volume":"56","author":[{"given":"Emilie","family":"Alirol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schrumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josu\u00e9","family":"Amici Heradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"de Patoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Quere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chappuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,10,16]]},"reference":[{"key":"key\n\t\t\t\t20170623052645_CIS886C1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052645_CIS886C2","doi-asserted-by":"crossref","first-page":"e333","DOI":"10.1371\/journal.pntd.0000333","article-title":"The burden of human African trypanosomiasis","volume":"2","author":"Fevre","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170623052645_CIS886C3","first-page":"71","article-title":"Human African trypanosomiasis (sleeping sickness): epidemiological update","volume":"81","year":"2006","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t20170623052645_CIS886C4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3201\/eid1602.090967","article-title":"Human African trypanosomiasis in areas without surveillance","volume":"16","author":"Chappuis","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170623052645_CIS886C5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1752-1505-5-7","article-title":"Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo","volume":"5","author":"Tong","year":"2011","journal-title":"Confl Health"},{"key":"key\n\t\t\t\t20170623052645_CIS886C6","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(03)14694-6","article-title":"The trypanosomiases","volume":"362","author":"Barrett","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052645_CIS886C7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2005.08.001","article-title":"Clinical aspects of 2541 patients with second stage human African trypanosomiasis","volume":"97","author":"Blum","year":"2006","journal-title":"Acta Trop"},{"key":"key\n\t\t\t\t20170623052645_CIS886C8","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20170623052645_CIS886C9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4269\/ajtmh.1949.s1-29.173","article-title":"Mel B in the treatment of human trypanosomiasis","volume":"29","author":"Friedheim","year":"1949","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t20170623052645_CIS886C10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-3156.2001.00710.x","article-title":"Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis","volume":"6","author":"Blum","year":"2001","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20170623052645_CIS886C11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(95)90673-8","article-title":"Risk factors for encephalopathy and mortality during melarsoprol treatment of Trypanosoma brucei gambiense sleeping sickness","volume":"89","author":"Pepin","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170623052645_CIS886C12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-3156.2001.00725.x","article-title":"Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment","volume":"6","author":"Burri","year":"2001","journal-title":"Trop Med Int Health"},{"key":"key\n\t\t\t\t20170623052645_CIS886C13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0035-9203(99)90151-7","article-title":"Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda","volume":"93","author":"Legros","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170623052645_CIS886C14","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1406.071266","article-title":"High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo","volume":"14","author":"Robays","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"key\n\t\t\t\t20170623052645_CIS886C15","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0169-4758(86)90087-6","article-title":"Difiuoromethylornithine in the treatment of African trypanosomiasis","volume":"2","author":"Schechter","year":"1986","journal-title":"Parasitol Today"},{"key":"key\n\t\t\t\t20170623052645_CIS886C16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bmj.39485.592674.BE","article-title":"Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study","volume":"336","author":"Priotto","year":"2008","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20170623052645_CIS886C17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1086\/432576","article-title":"Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis","volume":"41","author":"Chappuis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052645_CIS886C18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2471\/BLT.06.031955","article-title":"Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo","volume":"84","author":"Balasegaram","year":"2006","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t20170623052645_CIS886C19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.trstmh.2008.09.005","article-title":"Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Medecins Sans Frontieres programmes","volume":"103","author":"Balasegaram","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170623052645_CIS886C20","first-page":"475","article-title":"Clinical trials with \u201cnifurtimox\u201d in African trypanosomiasis","volume":"57","author":"Janssens","year":"1977","journal-title":"Ann Soc Belg Med Trop"},{"key":"key\n\t\t\t\t20170623052645_CIS886C21","first-page":"37","article-title":"Clinical trial of nifurtimox in human African trypanosomiasis","volume":"64","author":"Moens","year":"1984","journal-title":"Ann Soc Belg Med Trop"},{"key":"key\n\t\t\t\t20170623052645_CIS886C22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0035-9203(89)90270-8","article-title":"An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire","volume":"83","author":"Pepin","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170623052645_CIS886C23","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pntd.0000064","article-title":"Nifurtimox plus eflornithine for late-stage sleeping sickness in Uganda: a case series","volume":"1","author":"Checchi","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170623052645_CIS886C24","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pctr.0010039","article-title":"Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda","volume":"1","author":"Priotto","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"key\n\t\t\t\t20170623052645_CIS886C25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170623052645_CIS886C26","author":"World Health Organization. WHO includes combination of eflornithine and nifurtimox in its Essential List of Medicines for the treatment of human African trypanosomiasis","year":"2009"},{"key":"key\n\t\t\t\t20170623052645_CIS886C27","article-title":"A multicenter, open label, phase III study of therapeutic use of the co-administration of nifurtimox and eflornithine (NECT) for human African trypanosomiasis (NECT FIELD): safety profile in children during initial hospitalization","author":"Valverde Mordt"},{"key":"key\n\t\t\t\t20170623052645_CIS886C28","first-page":"169","article-title":"A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T. B. gambiense trypanosomiasis","volume":"58","author":"Magnus","year":"1978","journal-title":"Ann Soc Belg Med Trop"},{"key":"key\n\t\t\t\t20170623052645_CIS886C29","first-page":"384","article-title":"The haematocrit centrifuge technique for the diagnosis of African trypanosomiasis","volume":"27","author":"Woo","year":"1970","journal-title":"Acta Trop"},{"key":"key\n\t\t\t\t20170623052645_CIS886C30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0035-9203(79)90092-0","article-title":"Trypanosoma brucei: miniature anion-exchange centrifugation technique for detection of low parasitaemias: adaptation for field use","volume":"73","author":"Lumsden","year":"1979","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key\n\t\t\t\t20170623052645_CIS886C31","doi-asserted-by":"crossref","first-page":"e1000115","DOI":"10.1371\/journal.pmed.1000115","article-title":"Research ethics review in humanitarian contexts: the experience of the independent ethics review board of Medecins Sans Frontieres","volume":"6","author":"Schopper","year":"2009","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t20170623052645_CIS886C32","first-page":"196","article-title":"The clinical evaluation of chemotherapeutic agents in cancer","volume-title":"Evaluation of chemotherapeutic agents","author":"Karnofsky","year":"1949"},{"issue":"suppl 2","key":"key\n\t\t\t\t20170623052645_CIS886C33","first-page":"41","article-title":"Congenital Chagas disease: experience in the Hospital de Ninos, Ricardo Gutierrez, Buenos Aires, Argentina","volume":"38","author":"Altcheh","year":"2005","journal-title":"Rev Soc Bras Med Trop"},{"key":"key\n\t\t\t\t20170623052645_CIS886C34","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1191\/0960327106het653oa","article-title":"Toxic side effects of drugs used to treat Chagas\u2019 disease (American trypanosomiasis)","volume":"25","author":"Castro","year":"2006","journal-title":"Hum Exp Toxicol"},{"key":"key\n\t\t\t\t20170623052645_CIS886C35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MPH.0b013e3181f47061","article-title":"A phase 1 study of nifurtimox in patients with relapsed\/refractory neuroblastoma","volume":"33","author":"Saulnier Sholler","year":"2011","journal-title":"J Pediatr Hematol Oncol"},{"key":"key\n\t\t\t\t20170623052645_CIS886C36","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1086\/656917","article-title":"Tolerance and safety of nifurtimox in patients with chronic Chagas disease","volume":"51","author":"Jackson","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170623052645_CIS886C37","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1371\/journal.pntd.0000720","article-title":"NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness","volume":"4","author":"Yun","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t20170623052645_CIS886C38","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1017\/S0031182012000169","article-title":"Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis","volume":"139","author":"Simarro","year":"2012","journal-title":"Parasitology"},{"key":"key\n\t\t\t\t20170623052645_CIS886C39","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1128\/AAC.00246-11","article-title":"Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness","volume":"55","author":"Kaiser","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/56\/2\/195\/17851211\/cis886.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T20:04:29Z","timestamp":1503432269000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cis886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,16]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,10,16]]},"published-print":{"date-parts":[[2013,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cis886","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10,16]]}}}